Valuation: Clover Corporation Limited

Market Cap 130M 89.88M 78.83M 73.01M 67.18M 127M 8.6B 870M 341M 4.22B 337M 330M 14.59B P/E 2024
54x
P/E 2025 13.2x
Enterprise Value 123M 85.53M 75.02M 69.48M 63.93M 121M 8.19B 828M 325M 4.02B 321M 314M 13.88B EV / Sales 2024
1.29x
EV / Sales 2025 1x
Free-Float
81.18%
Yield 2024
1.53%
Yield 2025 3.15%
1 day+3.31%
1 week+4.70%
Current month-7.69%
1 month-8.77%
3 months-22.00%
6 months-1.27%
Current year-1.27%
1 week 0.7
Extreme 0.705
0.78
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.22
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Director/Board Member - 10/11/2014
Date Insider Type Main position Quantity % Market Cap.
11-17Sell

Chief Executive Officer

255,199 0.1528%
11-17Buy

Chief Executive Officer

529,638 0.3171%
11-05Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+3.31%+4.70%+50.00%-36.07% 87.21M
-1.99%-6.23%+28.92%+77.59% 13B
-2.97%+2.29%-26.11%+245.29% 7.95B
-0.75%-1.18%-20.28%-55.53% 2.3B
+2.15%-2.40% - - 1.46B
+0.84%-6.80%-78.66%-64.94% 1.45B
-0.80%+0.74%+33.52%-4.60% 1.36B
+1.83%-1.48%-29.63%-25.77% 1.23B
-0.35%-0.55%+18.56%+49.14% 1.23B
+3.92%+2.16%-61.12%-63.49% 1.13B
Average +0.52%-0.57%-9.42%+13.51% 3.12B
Weighted average by Cap. -1.33%+0.06%-0.85%+90.25%

Financials

2024 2025
Net sales 62.21M 43.16M 37.86M 35.06M 32.26M 61.02M 4.13B 418M 164M 2.03B 162M 159M 7.01B 86M 59.67M 52.34M 48.47M 44.6M 84.36M 5.71B 578M 227M 2.8B 224M 219M 9.69B
Net income 1.52M 1.05M 922K 854K 786K 1.49M 101M 10.18M 3.99M 49.41M 3.95M 3.86M 171M 7.02M 4.87M 4.27M 3.95M 3.64M 6.88M 466M 47.12M 18.48M 229M 18.28M 17.88M 790M
Net Debt -1.87M -1.3M -1.14M -1.06M -971K -1.84M -124M -12.58M -4.93M -61.05M -4.88M -4.77M -211M -6.26M -4.34M -3.81M -3.53M -3.25M -6.14M -416M -42.06M -16.5M -204M -16.31M -15.96M -705M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
13/07/26 A$0.7800 +3.31% 34,306
10/07/26 A$0.7550 -0.66% 12,038
09/07/26 A$0.7600 -0.65% 2,677
08/07/26 A$0.7650 +1.32% 439,128
07/07/26 A$0.7550 -1.31% 9,913
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Annual profits - Rate of surprise